Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific SARS-CoV-2 Test Gets Expanded FDA Emergency Use Authorization

NEW YORK – Thermo Fisher Scientific said on Tuesday that the US Food and Drug Administration has further expanded emergency use authorization for its real-time PCR test for SARS-CoV-2.

The test, called Applied Biosystems TaqPath COVID-19 Combo Kit, initially received EUA on March 13, which was expanded on March 24 and April 20.

The new expansion increases the number of PCR instruments and types of reagents and consumables labs can use to run the test. Labs can now run the test on specific configurations of the QuantStudio 7 Flex and QuantStudio 5 real-time PCR instruments, which significantly increases the number of instruments available for testing.

In addition, labs can now use the firm's MagMax viral/pathogen II nucleic isolation kit, as well as additional types of microplates.

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.